Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds
BioPharma DiveGwendolyn WuOctober 6, 2026
The fundraise is the firm s largest to date, providing a lift for a European biotech industry that s fallen further behind its counterparts in the U.S. and China.